{"DataElement":{"publicId":"2201372","version":"1","preferredName":"American College of Surgeons Oncology Group Treatment Arm Randomization American College of Surgeons Oncology Group Treatment Arm Randomization Type","preferredDefinition":"information relating to an American College of Surgeons Oncology Group treatment arm randomization._the treatment arm for an American College of Surgeons Oncology Group trial assigned as a result of randomization.","longName":"ACOSOG_TXARM_RNDM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2201370","version":"1","preferredName":"American College of Surgeons Oncology Group Treatment Arm Randomization","preferredDefinition":"information relating to an American College of Surgeons Oncology Group treatment arm randomization.","longName":"ACOSOG_TXARM_RANDMIZ","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2688607","version":"1","preferredName":"American College of Surgeons Oncology Group Protocol Treatment Arm","preferredDefinition":"The American College of Surgeons Oncology Group (ACOSOG) is a cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.:A specific treatment protocol used in a clinical trial.","longName":"C19712:C15538","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American College of Surgeons Oncology Group","conceptCode":"C19712","definition":"A cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protocol Treatment Arm","conceptCode":"C15538","definition":"A specific treatment plan within a clinical trial that describes the activities a subject will be involved in as he or she progresses through the study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C2B6447-FE67-0965-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-10-10","modifiedBy":"ONEDATA","dateModified":"2007-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2453144","version":"1","preferredName":"Randomization","preferredDefinition":"The allocation of individuals to groups, e.g., for experimental and control regimens, by chance. (On-line Medical Dictionary)","longName":"C25196","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Randomization","conceptCode":"C25196","definition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6F49-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-02-27","modifiedBy":"ONEDATA","dateModified":"2006-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2C45BCA-6488-7026-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2201371","version":"1","preferredName":"American College of Surgeons Oncology Group Treatment Arm Randomization Type","preferredDefinition":"the treatment arm for an American College of Surgeons Oncology Group trial assigned as a result of randomization.","longName":"ACOSOG_TXARM_RNDM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"140","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SR + Brachytherapy and acquisition of specimens for Central Specimen Bank","valueDescription":"SR + Brachytherapy and acquisition of specimens for Central Specimen Bank","ValueMeaning":{"publicId":"2573654","version":"1","preferredName":"SR + Brachytherapy and acquisition of specimens for Central Specimen Bank","longName":"2573654","preferredDefinition":"SR + Brachytherapy and acquisition of specimens for Central Specimen Bank","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECC3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-21","modifiedBy":"SHIDED","dateModified":"2005-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"169776BF-B715-0789-E044-0003BA3F9857","beginDate":"2006-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-06-19","modifiedBy":"ONEDATA","dateModified":"2006-06-19","deletedIndicator":"No"},{"value":"Sublobar resection (SR) and acquisition of specimens for Central Specimen Bank","valueDescription":"Sublobar resection (SR) and acquisition of specimens for Central Specimen Bank","ValueMeaning":{"publicId":"2573653","version":"1","preferredName":"Sublobar resection (SR) and acquisition of specimens for Central Specimen Bank","longName":"2573653","preferredDefinition":"Sublobar resection (SR) and acquisition of specimens for Central Specimen Bank","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ECC2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-21","modifiedBy":"SHIDED","dateModified":"2005-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"169776BF-B720-0789-E044-0003BA3F9857","beginDate":"2006-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-06-19","modifiedBy":"ONEDATA","dateModified":"2006-06-19","deletedIndicator":"No"},{"value":"Exemestane: Neoadjuvant treatment for 16 weeks with exemestane 25 mg (1 tablet) once daily followed by surgery","valueDescription":"Exemestane: Neoadjuvant treatment for 16 weeks with exemestane 25 mg (1 tablet) once daily followed by surgery","ValueMeaning":{"publicId":"2576599","version":"1","preferredName":"Exemestane: Neoadjuvant treatment for 16 weeks with exemestane 25 mg (1 tablet) once daily followed by surgery","longName":"2576599","preferredDefinition":"Exemestane: Neoadjuvant treatment for 16 weeks with exemestane 25 mg (1 tablet) once daily followed by surgery","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F844-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"CAMPBELB","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"169776BF-B731-0789-E044-0003BA3F9857","beginDate":"2006-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-06-19","modifiedBy":"ONEDATA","dateModified":"2006-06-19","deletedIndicator":"No"},{"value":"Letrozole: Neoadjuvant treatment for 16 weeks with letrozole 2.5 mg (1 capsule) once daily followed by surgery","valueDescription":"Letrozole: Neoadjuvant treatment for 16 weeks with letrozole 2.5 mg (1 capsule) once daily followed by surgery","ValueMeaning":{"publicId":"2576600","version":"1","preferredName":"Letrozole: Neoadjuvant treatment for 16 weeks with letrozole 2.5 mg (1 capsule) once daily followed by surgery","longName":"2576600","preferredDefinition":"Letrozole: Neoadjuvant treatment for 16 weeks with letrozole 2.5 mg (1 capsule) once daily followed by surgery","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F845-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"CAMPBELB","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"169776BF-B742-0789-E044-0003BA3F9857","beginDate":"2006-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-06-19","modifiedBy":"ONEDATA","dateModified":"2006-06-19","deletedIndicator":"No"},{"value":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole (1 capsule) once daily followed by surgery","valueDescription":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole (1 capsule) once daily followed by surgery","ValueMeaning":{"publicId":"2576601","version":"1","preferredName":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole (1 capsule) once daily followed by surgery","longName":"2576601","preferredDefinition":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole (1 capsule) once daily followed by surgery","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F846-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"CAMPBELB","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"169776BF-B753-0789-E044-0003BA3F9857","beginDate":"2006-06-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-06-19","modifiedBy":"ONEDATA","dateModified":"2006-06-19","deletedIndicator":"No"},{"value":"Neoadjuvant treatment with FEC-75 12W, followed by Paclitaxel and Trastuzumab, 12W, surgery and Trastuzumab","valueDescription":"Neoadjuvant treatment with FEC-75 12W, followed by Paclitaxel and Trastuzumab, 12W, surgery and Trastuzumab","ValueMeaning":{"publicId":"2581512","version":"1","preferredName":"Neoadjuvant treatment with FEC-75 12W, followed by Paclitaxel and Trastuzumab, 12W, surgery and Trastuzumab","longName":"2581512","preferredDefinition":"Neoadjuvant treatment with FEC-75 12W, followed by Paclitaxel and Trastuzumab, 12W, surgery and Trastuzumab (total 52W)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B75-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-31","modifiedBy":"CAMPBELB","dateModified":"2006-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"211DF69C-AB0E-07B5-E044-0003BA3F9857","beginDate":"2006-10-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"Neoadjuvant treatment with Paclitaxel 12W and Trastuzamab 13W followed by FEC-75 and Trastuzumab, 12W, surgery and Trastuzumab","valueDescription":"Neoadjuvant treatment with Paclitaxel 12W and Trastuzamab 13W followed by FEC-75 and Trastuzumab, 12W, surgery and Trastuzumab","ValueMeaning":{"publicId":"2581513","version":"1","preferredName":"Neoadjuvant treatment with Paclitaxel 12W and Trastuzamab 13W followed by FEC-75 and Trastuzumab, 12W, surgery and Trastuzumab","longName":"2581513","preferredDefinition":"Neoadjuvant treatment with Paclitaxel 12W and Trastuzamab 13W followed by FEC-75 and Trastuzumab, 12W, surgery and Trastuzumab (total 52W)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B76-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-31","modifiedBy":"CAMPBELB","dateModified":"2006-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"211DF69C-AB20-07B5-E044-0003BA3F9857","beginDate":"2006-10-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-31","modifiedBy":"ONEDATA","dateModified":"2006-10-31","deletedIndicator":"No"},{"value":"Open laparotomy and rectal resection","valueDescription":"Open laparotomy and rectal resection","ValueMeaning":{"publicId":"2718325","version":"1","preferredName":"Open laparotomy and rectal resection","longName":"2718325","preferredDefinition":"Open laparotomy and rectal resection","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D49DCE-8531-1834-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42D49DCE-8558-1834-E044-0003BA3F9857","beginDate":"2008-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-03","modifiedBy":"ONEDATA","dateModified":"2008-01-03","deletedIndicator":"No"},{"value":"Laparoscopic-assisted rectal resection","valueDescription":"Laparoscopic-assisted rectal resection","ValueMeaning":{"publicId":"2718326","version":"1","preferredName":"Laparoscopic-assisted rectal resection","longName":"2718326","preferredDefinition":"Laparoscopic-assisted rectal resection","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D49DCE-8541-1834-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42D49DCE-856A-1834-E044-0003BA3F9857","beginDate":"2008-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-03","modifiedBy":"ONEDATA","dateModified":"2008-01-03","deletedIndicator":"No"},{"value":"Patient chosen arm","valueDescription":"Patient chosen arm","ValueMeaning":{"publicId":"3130841","version":"1","preferredName":"Patient chosen arm","longName":"3130841","preferredDefinition":"Patient chosen arm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E2F1574-F0E0-0DDA-E040-BB89AD4334A0","latestVersionIndicator":"Yes","beginDate":"2010-08-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E2F1574-F0F9-0DDA-E040-BB89AD4334A0","beginDate":"2010-08-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-08-19","modifiedBy":"ONEDATA","dateModified":"2010-08-19","deletedIndicator":"No"},{"value":"CRS/HIPEC & System Therapy","valueDescription":"CRS/HIPEC & System Therapy","ValueMeaning":{"publicId":"3101979","version":"1","preferredName":"CRS/HIPEC & System Therapy","longName":"3101979","preferredDefinition":"CRS/HIPEC & System Therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8770702C-CDD9-7327-E040-BB89AD43441C","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"877048B2-116D-4ADE-E040-BB89AD43064A","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","deletedIndicator":"No"},{"value":"Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12 FEC-75 q 3 weeks x 4 cycles + Trastuzumab weekly x 12","valueDescription":"Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12 FEC-75 q 3 weeks x 4 cycles + Trastuzumab weekly x 12","ValueMeaning":{"publicId":"3114706","version":"1","preferredName":"Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12 FEC-75 q 3 weeks x 4 cycles + Trastuzumab weekly x 12","longName":"3114706","preferredDefinition":"Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12 FEC-75 q 3 weeks x 4 cycles + Trastuzumab weekly x 12","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A17730D-67CD-89AA-E040-BB89AD4373AE","latestVersionIndicator":"Yes","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A17730D-67E6-89AA-E040-BB89AD4373AE","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"ONEDATA","dateModified":"2010-06-28","deletedIndicator":"No"},{"value":"FEC-75 q 3 weeks x 4 cycles Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12","valueDescription":"FEC-75 q 3 weeks x 4 cycles Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12","ValueMeaning":{"publicId":"3114707","version":"1","preferredName":"FEC-75 q 3 weeks x 4 cycles Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12","longName":"3114707","preferredDefinition":"FEC-75 q 3 weeks x 4 cycles Paclitaxel 80 mg/m^2 IV weekly x 12 + Trastuzumab weekly x 12","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A17730D-67F0-89AA-E040-BB89AD4373AE","latestVersionIndicator":"Yes","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A17730D-6809-89AA-E040-BB89AD4373AE","beginDate":"2010-06-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-28","modifiedBy":"ONEDATA","dateModified":"2010-06-28","deletedIndicator":"No"},{"value":"Systemic Therapy","valueDescription":"Systemic Therapy","ValueMeaning":{"publicId":"3102869","version":"1","preferredName":"Systemic Therapy","longName":"3102869","preferredDefinition":"(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8777A923-22E4-03B3-E040-BB89AD432D09","latestVersionIndicator":"Yes","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt name for Alliance","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8777A923-22FD-03B3-E040-BB89AD432D09","beginDate":"2010-05-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-25","modifiedBy":"ONEDATA","dateModified":"2010-05-25","deletedIndicator":"No"},{"value":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole 1 mg (1 capsule) once daily followed by surgery","valueDescription":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole 1 mg (1 capsule) once daily followed by surgery","ValueMeaning":{"publicId":"3128007","version":"1","preferredName":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole 1 mg (1 capsule) once daily followed by surgery","longName":"3128007","preferredDefinition":"Anastrozole: Neoadjuvant treatment for 16 weeks with anastrozole 1 mg (1 capsule) once daily followed by surgery","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7998B3-84BD-79FE-E040-BB89AD435E82","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D7998B3-84D6-79FE-E040-BB89AD435E82","beginDate":"2010-08-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-08-10","modifiedBy":"ONEDATA","dateModified":"2010-08-10","deletedIndicator":"No"},{"value":"Stereotactic body radiation therapy","valueDescription":"Stereotactic Body Radiation Therapy","ValueMeaning":{"publicId":"3018437","version":"1","preferredName":"Stereotactic Body Radiation Therapy","longName":"3018437v1.00","preferredDefinition":"Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stereotactic Body Radiation Therapy","conceptCode":"C118286","definition":"Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D0D75B-934E-89F8-E040-BB89AD433425","latestVersionIndicator":"Yes","beginDate":"2010-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-02","modifiedBy":"KUMMEROA","dateModified":"2023-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97A08B30-B850-C7E2-E040-BB89AD432E13","beginDate":"2010-12-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-17","modifiedBy":"ONEDATA","dateModified":"2010-12-17","deletedIndicator":"No"},{"value":"Sublobar resection with or without brachytherapy","valueDescription":"Sublobar resection with or without brachytherapy","ValueMeaning":{"publicId":"3170639","version":"1","preferredName":"Sublobar resection with or without brachytherapy","longName":"3170639","preferredDefinition":"Sublobar resection with or without brachytherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97A08B30-B85B-C7E2-E040-BB89AD432E13","latestVersionIndicator":"Yes","beginDate":"2010-12-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97A08B30-B874-C7E2-E040-BB89AD432E13","beginDate":"2010-12-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-12-17","modifiedBy":"ONEDATA","dateModified":"2010-12-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2D1BF37-04F6-376F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-21","modifiedBy":"CAMPBELB","dateModified":"2010-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Randomization","type":"Preferred Question Text","description":"Randomization","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Treatment Arm","url":null,"context":"CTEP"}],"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F2D1C066-062B-3599-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-03-21","modifiedBy":"CAMPBELB","dateModified":"2010-12-17","changeDescription":"** ISO COMPLIANCE ** Lung Change Management 10/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}